Abstract: A diseased site, such as vascular dilatation site, is treated by first locally delivering to the site an agent that is effective to localize a desired drug and then systematically administering the drug.

Abstract: A method of modifying salts of alginic acid in situ for prevention and treatment of various intra-articular and extra-articular (spine) complications modifies the alginate in situ to an insoluble gel. This in situ modification provides a final product which can be compressed within the intra-articular space thus remaining localized. The modified material can have varied mechanical strengths and thus varied degradation times and can serve as a matrix for localizing and slowly releasing therapeutic agents. The modified material is biocompatible and biodegradable, thus requiring no reoperation for removal.

Abstract: Hydrogen-containing gas mixtures including saturated and unsaturated hydrocarbon gases, carbon monoxide and organic sulfur contaminants are purified by passing them over a hydrogenation catalyst containing phosphorus with the addition of predetermined limited amounts of water. The process makes it possible to produce hydrogen-containing gases which can be used for hydrogenation processes with the elimination or reduction of carbon monoxide, olefins and organic sulfur, all brought about simultaneously by passing the gas mixture over the same catalyst and in the same reactor.